Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$4.60
NASDAQLPCN
Open
$4.38
Change
$0.23 (5.26%)
Day's Range
$4.32 - $4.73
52-Week Range
$3.20 - $11.79
Volume
19.8K
Market Cap
$24.6M
Currency in USD.
Quote data delayed by at least 15 minutes.